| 1 |
33179295 | The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation. | 2021 May |
3 |
| 2 |
33440670 | Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review. | 2021 Jan 11 |
1 |
| 3 |
33935512 | The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. | 2021 |
2 |
| 4 |
32134727 | Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease. | 2020 Mar 5 |
2 |
| 5 |
32564268 | Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran. | 2020 Aug |
1 |
| 6 |
32899083 | Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report. | 2020 Sep 4 |
4 |
| 7 |
30658513 | Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants. | 2019 Jan 17 |
1 |
| 8 |
30850966 | Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis. | 2019 Jun |
2 |
| 9 |
31104266 | A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients. | 2019 Dec |
2 |
| 10 |
29867495 | Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect. | 2018 |
2 |
| 11 |
30100750 | The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty. | 2018 |
1 |
| 12 |
27261537 | Pharmacogenetics of dabigatran etexilate interindividual variability. | 2016 Aug |
3 |
| 13 |
27614009 | Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender. | 2016 Nov 1 |
13 |
| 14 |
24212377 | Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayers. | 2014 Feb |
5 |
| 15 |
24212379 | Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis. | 2014 Feb |
6 |
| 16 |
24988246 | The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. | 2014 |
1 |
| 17 |
23239178 | Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism. | 2013 Feb |
2 |
| 18 |
23467860 | Genetic determinants of dabigatran plasma levels and their relation to bleeding. | 2013 Apr 2 |
1 |